We investigated the effect of a local administered drug combination targeting the tumor vasculature for antitumor treatment of ILP with rhTNF-α versus ILP with chemotherapy alone on cEPC in melanoma and high-grade sarcoma patients. The gene discussed is XIAP; the disease is neoplasm.